Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Set7 deletion attenuates isoproterenol-induced cardiac fibrosis and delays cardiac dysfunction.
Lunardon G, de Oliveira Silva T, Lino CA, Lu YW, Miranda JB, Asprino PF, de Almeida Silva A, Nepomuceno GT, Irigoyen MCC, Carneiro-Ramos MS, Takano APC, Martinho HDS, Barreto-Chaves MLM, Wang DZ, Diniz GP. Lunardon G, et al. Among authors: asprino pf. Clin Sci (Lond). 2022 Nov 30;136(21):1537-1554. doi: 10.1042/CS20220466. Clin Sci (Lond). 2022. PMID: 36285636
Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy.
Donnard E, Asprino PF, Correa BR, Bettoni F, Koyama FC, Navarro FC, Perez RO, Mariadason J, Sieber OM, Strausberg RL, Simpson AJ, Jardim DL, Reis LF, Parmigiani RB, Galante PA, Camargo AA. Donnard E, et al. Among authors: asprino pf. Oncotarget. 2014 Oct 15;5(19):9199-213. doi: 10.18632/oncotarget.2374. Oncotarget. 2014. PMID: 25193853 Free PMC article.
Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM, Habr-Gama A, Quevedo Bde S, Felício NM, Bettoni F, Koyama FC, Asprino PF, Galante PA, Gama-Rodrigues J, Camargo AA, Perez RO, Parmigiani RB. Lopes-Ramos CM, et al. Among authors: asprino pf. BMC Med Genomics. 2014 Dec 11;7:68. doi: 10.1186/s12920-014-0068-7. BMC Med Genomics. 2014. PMID: 25496125 Free PMC article.
Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer.
Lopes-Ramos C, Koyama FC, Habr-Gama A, Salim AC, Bettoni F, Asprino PF, França GS, Gama-Rodrigues J, Parmigiani RB, Perez RO, Galante PA, Camargo AA. Lopes-Ramos C, et al. Among authors: asprino pf. Cancer Genet. 2015 Jun;208(6):319-26. doi: 10.1016/j.cancergen.2015.03.010. Epub 2015 Mar 25. Cancer Genet. 2015. PMID: 25963525
The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation.
Carpinetti P, Donnard E, Bettoni F, Asprino P, Koyama F, Rozanski A, Sabbaga J, Habr-Gama A, Parmigiani RB, Galante PA, Perez RO, Camargo AA. Carpinetti P, et al. Oncotarget. 2015 Nov 10;6(35):38360-71. doi: 10.18632/oncotarget.5256. Oncotarget. 2015. PMID: 26451609 Free PMC article.
NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients.
Jandrey EHF, Moura RP, Andrade LNS, Machado CL, Campesato LF, Leite KRM, Inoue LT, Asprino PF, da Silva APM, de Barros ACSD, Carvalho A, de Lima VC, Carraro DM, Brentani HP, da Cunha IW, Soares FA, Parmigiani RB, Chammas R, Camargo AA, Costa ÉT. Jandrey EHF, et al. Among authors: asprino pf. NPJ Breast Cancer. 2019 Apr 5;5:11. doi: 10.1038/s41523-019-0106-x. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 30963110 Free PMC article.
32 results